The Efficacy of a Subanesthetic Doses of IV Ketamine in the Treatment Drug Resistant Epilepsy

Clinical trial NCT05019885 · RECRUITING

Trial details

NCT number: NCT05019885
Sponsor: Madeline Fields
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Drug Resistant Epilepsy Medically Refractory Epilepsy Refractory Epilepsy

Start date: 2022-08-26
Primary completion: 2026-03-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.